Lantern Pharma Inc. (LTRN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Lantern Pharma Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.93x | -1.65x | -2.91x | -4.60x | -7.04x | -20.27x |
| P/B Ratio | 0.01x | 1.62x | 1.13x | 1.17x | 1.22x | 6.08x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 2.40x | 5.83x | 16.18x | 20.99x | 31.26x | 36.64x |
| Quick Ratio | 2.40x | 5.83x | 16.18x | 20.99x | 31.26x | 36.64x |
| Leverage | ||||||
| Debt/Equity | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.01x |
YoY = year-over-year change. Source: FMP..